Inventor · disambiguated record
Wei Peng
Also filed as: PENG WEI · PENG WEI-JEN
26 granted patents·18 pending applications·36 citations·filing 1997–2025
93Inventor score
Files withNOVOZYMES AS14WUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD7UNIV SUN YAT SEN6HOECHST CELANESE CORP5BIOMICS BIOTECHNOLOGIES CO LTD2
Top patents by PatentIndex Score
44 records- 0192US10711259B2Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activityNOVOZYMES AS·Filed 2015·Granted Jul 14, 2020·7 cites·13 claims
- 0283US2023357740A1Compositions Comprising Polypeptides having Xylanase Activity and Polypeptides having Arabinofuronosidase ActivityNOVOZYMES AS·Filed 2023·Application pending·0 cites
- 0380US11788079B2Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activityNOVOZYMES AS·Filed 2022·Granted Oct 17, 2023·0 cites·16 claims
- 0479US9388133B2Pyrrole sulfonamide derivative, preparation method for same, and medical application thereofJIANGSU HANSOH PHARMACEUTICAL CO LTD·Filed 2013·Granted Jul 12, 2016·5 cites·21 claims
- 0578US2024425833A1PolypeptidesNOVOZYMES AS·Filed 2024·Application pending·0 cites
- 0676US11926852B2Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activityNOVOZYMES AS·Filed 2021·Granted Mar 12, 2024·0 cites·18 claims
- 0776US11793849B2Method of Chinese herbal medicine extract used for treating multiple diseases caused by drug resistant bacteria infectionUNIV SUN YAT SEN·Filed 2021·Granted Oct 24, 2023·0 cites·3 claims
- 0875US11654174B2Method of chinese herbal medicine extract used for treating multiple diseases caused by drug resistant bacteria infectionUNIV SUN YAT SEN·Filed 2021·Granted May 23, 2023·0 cites·3 claims
- 0972US11946079B2Method for producing a protein hydrolysate using an endopeptidase and a carboxypeptidaseNOVOZYMES AS·Filed 2022·Granted Apr 2, 2024·0 cites·3 claims
- 1072US11053490B2Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activityNOVOZYMES AS·Filed 2020·Granted Jul 6, 2021·0 cites·15 claims
- 1171US11491198B2Method of chinese herbal medicine extract used for treating multiple diseases caused by drug resistant bacteria infectionUNIV SUN YAT SEN·Filed 2020·Granted Nov 8, 2022·0 cites·3 claims
- 1270US12110518B2PolypeptidesNOVOZYMES AS·Filed 2019·Granted Oct 8, 2024·0 cites·15 claims
- 1365US2025189547A1Surface-enhanced raman nanoparticle and detection method for fentanylsSHENZHEN CUSTOMS INDUSTRIAL PRODUCTS TESTING TECH CENTER·Filed 2024·Application pending·0 cites
- 1463US11254919B2Polynucleotide encoding polypeptide having carboxypeptidase activityNOVOZYMES AS·Filed 2018·Granted Feb 22, 2022·0 cites·20 claims
- 1563US2025387402A1Polysubstituted benzene compound and preparation method and use thereofEVOPOINT BIOSCIENCES CO LTD·Filed 2025·Application pending·0 cites
- 1661US2025074908A1Salt of rock inhibitor, crystal form of salt, composition, and pharmaceutical useWUHAN CREATERNA SCIENCE AND TECH CO LTD·Filed 2023·Application pending·0 cites
- 1760US12390472B2Polysubstituted benzene compound and preparation method and use thereofSUZHOU SINOVENT PHARMACEUTICALS CO LTD·Filed 2019·Granted Aug 19, 2025·0 cites·8 claims
- 1859US11499163B2Expression method of Haemocoagulase Acutus (Halase) recombinant proteinUNIV SUN YAT SEN·Filed 2018·Granted Nov 15, 2022·0 cites·9 claims
- 1959US11154582B2Method of chinese herbal medicine extract used for treating multiple diseases caused by drug resistant bacteria infectionUNIV SUN YAT SEN·Filed 2018·Granted Oct 26, 2021·0 cites·3 claims
- 2059US9896423B2Deuterium substituted 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine compound or derivatives thereof, and pharmaceutical composition and use thereofJIANGSU JIBEIER PHARMACEUTICAL CO LTD·Filed 2014·Granted Feb 20, 2018·1 cites·6 claims
- 2158US12503444B2Compound containing benzene ring and application thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2020·Granted Dec 23, 2025·0 cites·10 claims
- 2256US12377083B2Lysophosphatidic acid receptor antagonist and preparation method thereforWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2020·Granted Aug 5, 2025·0 cites·3 claims
- 2356US2025325494A1Composition for organ-specific delivery of nucleic acidTHEMEDIUM THERAPEUTICS CO LTD·Filed 2025·Application pending·0 cites
- 2456US2025188013A1Lipid compound and use thereofTHEMEDIUM THERAPEUTICS CO LTD·Filed 2025·Application pending·0 cites
- 2556US2024239735A1Acid addition salt of rock inhibitor, and crystal form, composition and pharmaceutical use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2022·Application pending·0 cites
- 2655US5858329AMRI diagnostic procedures using tripodal pyridinyl metal complexesHOECHST CELANESE CORP·Filed 1997·Granted Jan 12, 1999·7 cites·20 claims
- 2755US2024307885A1Improved fiber-wash in corn wet-millingNOVOZYMES AS·Filed 2021·Application pending·0 cites
- 2852US2022002690A1Polypeptides having lipase activity and use thereof for wheat separationNOVOZYMES AS·Filed 2019·Application pending·0 cites
- 2951US2023257376A1Rock inhibitor, and preparation method therefor and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2021·Application pending·0 cites
- 3050US12378204B2Triazole compounds and preparation method therefor and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2020·Granted Aug 5, 2025·0 cites·8 claims
- 3149US5869025ATripodal aromatic heterocycle carboxamide MRI contrast agentsHOECHST CELANESE CORP·Filed 1997·Granted Feb 9, 1999·5 cites·9 claims
- 3249US5824288AThio-substituted pyridines as MRI ligand precursorsHOECHST CELANESE CORP·Filed 1997·Granted Oct 20, 1998·4 cites·18 claims
- 3348US5820851ATripodal pyridine ligands as MRI contrast agentsHOECHST CELANESE CORP·Filed 1997·Granted Oct 13, 1998·4 cites·22 claims
- 3448US2023118751A1Fused ring compound and application thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2020·Application pending·0 cites
- 3547US11591342B2Heterocyclic compound, application thereof and pharmaceutical composition comprising sameSUZHOU SINOVENT PHARMACEUTICALS CO LTD·Filed 2019·Granted Feb 28, 2023·0 cites·14 claims
- 3647US2023050653A1Rock inhibitor and preparation method therefor and use thereofWUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD·Filed 2020·Application pending·0 cites
- 3746US10927359B2Compositions comprising polypeptides having galactanase activity and polypeptides having beta-galactosidase activityNOVOZYMES AS·Filed 2017·Granted Feb 23, 2021·0 cites·18 claims
- 3843US2023115907A1Heterocyclic compound and pharmaceutical composition, preparation method, intermediate and use thereofEVOPOINT BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 3941US2019106690A1Cellulase Variants And Polynucleotides Encoding SameNOVOZYMES AS·Filed 2016·Application pending·0 cites
- 4040US2020165591A1Combined use of at least one endo-protease and at least one exo-protease in an ssf process for improving ethanol yieldNOVOZYMES AS·Filed 2017·Application pending·0 cites
- 4139US9820942B2Lipidosome preparation, preparation method and application thereofBIOMICS BIOTECHNOLOGIES CO LTD·Filed 2013·Granted Nov 21, 2017·0 cites·17 claims
- 4232US5869026ATripodal carboxamide ligands for MRI contrast agentsHOECHST CELANESE CORP·Filed 1997·Granted Feb 9, 1999·3 cites·5 claims
- 4331US2016303156A1Pharmaceutical composition comprising naringin and levocetirizine hydrochloride, and preparations thereofUNIV SUN YAT SEN·Filed 2015·Application pending·0 cites
- 4430US2019380963A1Liposome preparation having high-content cationic lipid compound and use thereofBIOMICS BIOTECHNOLOGIES CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wei Peng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →